The pharmacotherapy of male hypogonadism besides androgens.

@article{Corona2015ThePO,
  title={The pharmacotherapy of male hypogonadism besides androgens.},
  author={Giovanni Vito Corona and Giulia Rastrelli and Mario Maggi},
  journal={Expert opinion on pharmacotherapy},
  year={2015},
  volume={16 3},
  pages={
          369-87
        }
}
INTRODUCTION Adulthood male hypogonadism (HG) is the most common form of HG. Although testosterone (T) replacement therapy (TRT) is the most common way of treating HG, other options are available depending on patient's needs and expectations. AREAS COVERED We analyze alternative options to TRT as a medical intervention in treating HG. Gonadotropin (Gn) therapy is the treatment of choice in men with secondary HG (sHG), who require fertility. Gonadotropin-releasing hormone therapy represents an… CONTINUE READING
3
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 139 REFERENCES

Standard operating procedures: pubertas tarda/delayed puberty--male.

  • The journal of sexual medicine
  • 2013
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…